Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Roth

Showing results (111-120 of 352) with videos related to

Pageof 36
Sort By:
Oncogene|November 20, 2002
Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cellsTongyu Lin, Xuefeng Huang, Jian Gu, et al.
Cancer Research|May 6, 2004
Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cellsFutoshi Uno, Jiichiro Sasaki, Masahiko Nishizaki, et al.
Cancer Research|March 13, 2025
Mutation of SMARCA4 Induces Cancer Cell-Intrinsic Defects in the Enhancer Landscape and Resistance to ImmunotherapyYawen Wang, Ismail M Meraz, Md Qudratullah, et al.
Gynecologic Oncology|June 8, 2002
Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cellsJanos L Tanyi, Ruth Lapushin, Astrid Eder, et al.
Carcinogenesis|November 15, 2018
A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancerYajie Zhang, Jack A Roth, Hao Yu, et al.
The Annals of Thoracic Surgery|August 28, 2007
Sarcomatoid carcinoma of the lung: a predictor of poor prognosisLinda W Martin, Arlene M Correa, Nelson G Ordonez, et al.
Cancer Immunology Research|January 18, 2018
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic <i>Kras</i>-Mutant Mouse Lung Cancer ModelsIsmail M Meraz, Mourad Majidi, Xiaobo Cao, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 6, 2004
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patientsAra A Vaporciyan, Arlene M Correa, David C Rice, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 7, 2011
The prognostic factors of chest wall metastasis resectionSeyed-Hamid Hemmati, Arlene M Correa, Garrett L Walsh, et al.
Cancer Research|July 10, 2007
Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagyShoichiro Ohtani, Arifumi Iwamaru, Wuguo Deng, et al.
Pageof 36

Showing results (111-120 of 352) with videos related to

Sort By:
Pageof 36
Oncogene|November 20, 2002
Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cellsTongyu Lin, Xuefeng Huang, Jian Gu, et al.
Cancer Research|May 6, 2004
Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cellsFutoshi Uno, Jiichiro Sasaki, Masahiko Nishizaki, et al.
Cancer Research|March 13, 2025
Mutation of SMARCA4 Induces Cancer Cell-Intrinsic Defects in the Enhancer Landscape and Resistance to ImmunotherapyYawen Wang, Ismail M Meraz, Md Qudratullah, et al.
Gynecologic Oncology|June 8, 2002
Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cellsJanos L Tanyi, Ruth Lapushin, Astrid Eder, et al.
Carcinogenesis|November 15, 2018
A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancerYajie Zhang, Jack A Roth, Hao Yu, et al.
The Annals of Thoracic Surgery|August 28, 2007
Sarcomatoid carcinoma of the lung: a predictor of poor prognosisLinda W Martin, Arlene M Correa, Nelson G Ordonez, et al.
Cancer Immunology Research|January 18, 2018
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic <i>Kras</i>-Mutant Mouse Lung Cancer ModelsIsmail M Meraz, Mourad Majidi, Xiaobo Cao, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 6, 2004
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patientsAra A Vaporciyan, Arlene M Correa, David C Rice, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 7, 2011
The prognostic factors of chest wall metastasis resectionSeyed-Hamid Hemmati, Arlene M Correa, Garrett L Walsh, et al.
Cancer Research|July 10, 2007
Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagyShoichiro Ohtani, Arifumi Iwamaru, Wuguo Deng, et al.
Pageof 36